Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
Thursday, January 04, 2018
Beacon Discovery has entered into a collaboration agreement with Janssen Pharmaceuticals.
read more
Thursday, January 04, 2018
BLI has entered into a research collaboration and license agreement with Pfizer focused on optimizing BLI's proprietary Beacon Optofluidic platform.
read more
Friday, December 22, 2017
SSCI has increased capacity in response to industry demand for the company’s cGMP particle characterization services by implementing Malvern’s next-generation laser diffraction instrument Mastersizer 3000.
read more
Tuesday, December 19, 2017
ClearPath has initiated a third research collaboration with Astellas Pharma to combat infections.
read more
Tuesday, December 19, 2017
Avista has completed extensive facility upgrades at its Longmont, Colorado site.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced the exclusive launch of generic Viread tablets 300 mg in the U.S.
read more
Thursday, December 14, 2017
Izana Bioscience has launched as a new clinical-stage translational medicine company.
read more
Thursday, December 14, 2017
BioVectra announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate.
read more
Thursday, December 14, 2017
reMYND and Novo Nordisk have entered into a license agreement to further develop reMYND's ReS39 therapeutic program of diabetes.
read more
Wednesday, December 06, 2017
Carmot and Amgen will work to select therapeutic targets and identify drug candidates.
read more
Wednesday, December 06, 2017
Plasticell announced it will collaborate with Anthony Nolan to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.
read more
Tuesday, December 05, 2017
CSL and Vitaeris have entered into a collaboration and purchase option agreement to expedite the development of clazakizumab as a therapeutic option for solid organ transplant rejection.
read more
Tuesday, December 05, 2017
Xencor announced the company has earned a $10 million milestone payment from Amgen.
read more